SCHEMBL23743310

SCHEMBL23743310

c1ccc(-c2nc(-c3ccc(-c4ccc5ccccc5c4)cc3)nc(-c3cccc4c3-c3ccc5ccccc5c3C4(c3ccccc3)c3ccccc3)n2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.34
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ TP53 P04637 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ MAPT P10636 3/20 0.34
▸ HPGD P15428 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ NFKB1 P19838 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ NFKB2 Q00653 1/20 0.34
▸ RELA Q04206 1/20 0.34
▸ ATM Q13315 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ CHRNA1 P02708 1/20 0.33
▸ CHRNG P07510 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23743317 0.94 SMN1; SMN2 (0.37) ALDH1A1SMN1; SMN2KDM4ETP53HSD17B10
SCHEMBL23743308 0.93 MAPT (0.35) ALDH1A1SMN1; SMN2KDM4ETP53HSD17B10
SCHEMBL23743288 0.92 MAPT (0.39) ALDH1A1SMN1; SMN2KDM4ETP53HSD17B10
SCHEMBL23743299 0.91 MAPT (0.38) ALDH1A1SMN1; SMN2KDM4ETP53HSD17B10
SCHEMBL22868531 0.90 KDM4E (0.32) ALDH1A1SMN1; SMN2KDM4ETP53HSD17B10
SCHEMBL23743306 0.89 MAPT (0.36) ALDH1A1SMN1; SMN2KDM4ETP53HSD17B10
SCHEMBL24735898 0.88 MEN1 (0.38) ALDH1A1SMN1; SMN2KDM4ETP53HSD17B10
SCHEMBL23743421 0.87 CYP1A1 (0.35) ALDH1A1SMN1; SMN2KDM4ETP53HSD17B10
SCHEMBL25538506 0.86 PIM1 (0.40) ALDH1A1SMN1; SMN2KDM4ETP53HSD17B10
SCHEMBL22868526 0.86 PIM1 (0.36) ALDH1A1SMN1; SMN2KDM4ETP53HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210249607-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2021-08-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210249607-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OCIAD2, OCIAD1, OXER1 ALDH1A1 133/4885SMN1; SMN2 4181/4885KDM4E 4378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback